the UK question that gets asked weekly, answered properly
the UK question that gets asked weekly, answered properly. It is the sort of thing everyone half-believes and nobody writes down.
Two years and four months on a tier 3 list. Referral date and every letter kept, which turned out to matter when the service reorganised.
Four pharmacies, four prices, same product, same month. The spread was larger than I expected and none of them were the headline offer.
GP said no in the spring, specialist said yes eighteen months later. Same person, same numbers.
Sceptical readings welcome. The confident ones are the ones I distrust.
best — the order this archive was captured in
Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.
Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.
I would not read a supply notice as a shortage in your pharmacy tomorrow. They are not the same thing.
Same. My ICB threshold was different from the neighbouring one and nobody could tell me why.
the MHRA supply notices are published, read them before the panic threads
GP said no and specialist said yes is a very common sequence
Concentrations can differ between products and between pharmacies. Switching mid-titration means redoing the arithmetic rather than carrying the old unit count across.
Cosigning on discharge at goal. It catches people who have done everything right and did not know it was coming.
In England, specialist weight management services are commissioned locally, so eligibility criteria and waiting times differ by ICB. There is no single national threshold to quote.
England, Scotland, Wales and Northern Ireland are four different pathways
Not convinced — the US threads are a different system entirely and importing their advice here does real harm.
Pharmacy pricing on a private prescription is set by the pharmacy. The spread between them in a given month is routinely substantial, which is why a tracker built from member reports is more useful than any headline.